Insider · CIK 0001611468
Hoelscher Paul W.
Reports to the SEC for 3 companies · SAN MATEO, CA
Transactions
50
Companies
3
Filings
9
CIK
0001611468
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2026-06-12 | SGMTSagimet Biosciences Inc. · Stock Option (Right to Buy)A Award | — |
| 2025-06-09 | SGMTSagimet Biosciences Inc. · Stock Option (Right to Buy)A Award | — |
| 2024-06-05 | SGMTSagimet Biosciences Inc. · Stock Option (Right to Buy)A Award | — |
| 2024-04-01 | SGMTSagimet Biosciences Inc. · Stock Option (Right to Buy)A Award | — |
| 2023-06-06 | OKUROnKure Therapeutics, Inc. · Stock Option (right to buy)A Award | — |
| 2022-06-01 | OKUROnKure Therapeutics, Inc. · Stock Option (right to buy)A Award | — |
| 2022-04-20 | Horizon Therapeutics Public Ltd CoM Exercise/Conversion | +$1.11M |
| 2022-04-20 | Horizon Therapeutics Public Ltd CoS Sale | −$3.25M |
| 2022-04-20 | Horizon Therapeutics Public Ltd CoS Sale | −$2.48M |
| 2022-04-20 | Horizon Therapeutics Public Ltd CoStock Option (Right to Buy)M Exercise/Conversion | — |
| 2022-04-06 | Horizon Therapeutics Public Ltd CoM Exercise/Conversion | +$483K |
| 2022-04-06 | Horizon Therapeutics Public Ltd CoM Exercise/Conversion | +$4.1M |
| 2022-04-06 | Horizon Therapeutics Public Ltd CoS Sale | −$23.7M |
| 2022-04-06 | Horizon Therapeutics Public Ltd CoS Sale | −$10.1M |
| 2022-04-06 | Horizon Therapeutics Public Ltd CoStock Option (Right to Buy)M Exercise/Conversion | — |
| 2022-04-06 | Horizon Therapeutics Public Ltd CoStock Option (Right to Buy)M Exercise/Conversion | — |
| 2022-03-25 | Horizon Therapeutics Public Ltd CoS Sale | −$72.9K |
| 2022-03-24 | Horizon Therapeutics Public Ltd CoS Sale | −$163K |
| 2022-03-23 | Horizon Therapeutics Public Ltd CoM Exercise/Conversion | +$416K |
| 2022-03-23 | Horizon Therapeutics Public Ltd CoS Sale | −$2.87M |
| 2022-03-23 | Horizon Therapeutics Public Ltd CoS Sale | −$1.29M |
| 2022-03-23 | Horizon Therapeutics Public Ltd CoStock Option (Right to Buy)M Exercise/Conversion | — |
| 2022-03-07 | Horizon Therapeutics Public Ltd CoG Gift | — |
| 2022-03-07 | Horizon Therapeutics Public Ltd CoG Gift | — |
| 2022-03-07 | Horizon Therapeutics Public Ltd CoG Gift | — |
| 2022-03-07 | Horizon Therapeutics Public Ltd CoG Gift | — |
| 2022-01-21 | Horizon Therapeutics Public Ltd CoM Exercise/Conversion | — |
| 2022-01-21 | Horizon Therapeutics Public Ltd CoF Tax Payment | −$213K |
| 2022-01-21 | Horizon Therapeutics Public Ltd CoRestricted Stock Units (RSUs)M Exercise/Conversion | — |
| 2022-01-20 | OKUROnKure Therapeutics, Inc. · Stock Option (right to buy)A Award | — |
| 2022-01-05 | Horizon Therapeutics Public Ltd CoM Exercise/Conversion | — |
| 2022-01-05 | Horizon Therapeutics Public Ltd CoA Award | — |
| 2022-01-05 | Horizon Therapeutics Public Ltd CoF Tax Payment | −$5.16M |
| 2022-01-05 | Horizon Therapeutics Public Ltd CoRestricted Stock Units (RSU)M Exercise/Conversion | — |
| 2022-01-05 | Horizon Therapeutics Public Ltd CoRestricted Stock Units (RSU)M Exercise/Conversion | — |
| 2022-01-05 | Horizon Therapeutics Public Ltd CoRestricted Stock Units (RSU)M Exercise/Conversion | — |
| 2022-01-05 | Horizon Therapeutics Public Ltd CoRestricted Stock Units (RSU)M Exercise/Conversion | — |
| 2022-01-05 | Horizon Therapeutics Public Ltd CoRestricted Stock Units (RSU)M Exercise/Conversion | — |
| 2022-01-04 | Horizon Therapeutics Public Ltd CoRestricted Stock Units (RSU)A Award | — |
| 2021-12-28 | Horizon Therapeutics Public Ltd CoM Exercise/Conversion | +$137K |
| 2021-12-28 | Horizon Therapeutics Public Ltd CoS Sale | −$943K |
| 2021-12-28 | Horizon Therapeutics Public Ltd CoStock Option (Right to Buy)M Exercise/Conversion | — |
| 2021-12-03 | Horizon Therapeutics Public Ltd CoG Gift | — |
| 2021-08-25 | Horizon Therapeutics Public Ltd CoG Gift | — |
| 2021-08-25 | Horizon Therapeutics Public Ltd CoG Gift | — |
| 2021-07-28 | Horizon Therapeutics Public Ltd CoA Award | — |
| 2021-07-28 | Horizon Therapeutics Public Ltd CoF Tax Payment | −$395K |
| 2021-07-28 | Horizon Therapeutics Public Ltd CoPerformance Restricted Stock Units (PSUs)A Award | — |
| 2021-05-14 | Horizon Therapeutics Public Ltd CoS Sale | −$9.26M |
| 2021-02-17 | Horizon Therapeutics Public Ltd CoA Award | — |
Recent filings
- 4Hoelscher Paul W.0001104659-26-074052SEC(opens sec.gov)
- 4Hoelscher Paul W.0001104659-25-058221SEC(opens sec.gov)
- 4Hoelscher Paul W.0001104659-24-069632SEC(opens sec.gov)
- 4Hoelscher Paul W.0001104659-24-043263SEC(opens sec.gov)
- 4Hoelscher Paul W.0001209191-23-035564SEC(opens sec.gov)
- 4Hoelscher Paul W.0001209191-22-034178SEC(opens sec.gov)
- 4Hoelscher Paul W.0001209191-22-025455SEC(opens sec.gov)
- 4Hoelscher Paul W.0001209191-22-023845SEC(opens sec.gov)
- 4Hoelscher Paul W.0001209191-22-021151SEC(opens sec.gov)
Companies
Address
SAGIMET BIOSCIENCES INC. 155 BOVET ROAD, SUITE 303
SAN MATEO, CA, 94402